Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. The company provides delayed and sustained release, chewable, and orally disintegrating tablets. It also exports its products. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India.
Bafna Pharmaceuticals Dividend Announcement
• Bafna Pharmaceuticals announced a annually dividend of ₹0.06 per ordinary share which will be made payable on . Ex dividend date: 2013-09-19
• Bafna Pharmaceuticals's trailing twelve-month (TTM) dividend yield is -%
Bafna Pharmaceuticals Dividend History
| Ex-Div date | Dividend amount | Dividend type | Pay date |
|---|---|---|---|
| 2013-09-19 | ₹0.06 | annually |
Bafna Pharmaceuticals Dividend per year
Bafna Pharmaceuticals Dividend Yield
Bafna Pharmaceuticals current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Bafna Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:
Bafna Pharmaceuticals Financial Ratios
P/E ratio469.52
PEG ratio-91.19
P/B ratio2.31
ROE0.50%
Payout ratio0.00%
Current ratio1.96
Quick ratio1.24
Cash Ratio0.03
Bafna Pharmaceuticals Dividend FAQ
Does Bafna Pharmaceuticals stock pay dividends?
Bafna Pharmaceuticals does not currently pay dividends to its shareholders.
Has Bafna Pharmaceuticals ever paid a dividend?
No, Bafna Pharmaceuticals has no a history of paying dividends to its shareholders. Bafna Pharmaceuticals is not known for its dividend payments.
Why doesn't Bafna Pharmaceuticals pay dividends?
There are several potential reasons why Bafna Pharmaceuticals would choose not to pay dividends to their shareholders:
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Bafna Pharmaceuticals ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Bafna Pharmaceuticals has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Bafna Pharmaceuticals a dividend aristocrat?
Bafna Pharmaceuticals is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Bafna Pharmaceuticals a dividend king?
Bafna Pharmaceuticals is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Bafna Pharmaceuticals a dividend stock?
No, Bafna Pharmaceuticals is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Bafna Pharmaceuticals stocks?
To buy Bafna Pharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.
Place an order: Use the brokerage's trading platform to place an order to buy Bafna Pharmaceuticals stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
Place an order: Use the brokerage's trading platform to place an order to buy Bafna Pharmaceuticals stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.